BIOADAPTIVES, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
2620 REGATTA DRIVE, LAS VEGAS, NV, 89128
Mailing Address
2620 REGATTA DRIVE, LAS VEGAS, NV, 89128
Phone
(702) 659-8829
Fiscal Year End
1231
EIN
462592228
Financial Overview
FY2025
$262K
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | December 3, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 4 Insider stock transaction report | November 4, 2025 | View on SEC |
| 4 Insider stock transaction report | October 6, 2025 | View on SEC |
| 4 Insider stock transaction report | September 3, 2025 | View on SEC |
Annual Reports
10-K
April 14, 2026
- Over a decade of R&D invested in natural, plant-based supplements.
- Upcoming market launch for MyndMed and Zeranovia planned for 2025.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.